Recovery after spinal cord injury by modulation of the proteoglycan receptor PTPσ. - NervGen

Skip to content

Home
About
Science
Pipeline
Patient & Caregiver Resources
Investors
Contact Us

Home
About
Science
Pipeline
Patient & Caregiver Resources
Investors
Contact Us

Home
About
Science
Pipeline
Patient & Caregiver Resources
Investors
Contact Us

Home
About
Science
Pipeline
Patient & Caregiver Resources
Investors
Contact Us

Experimental Neurology. Rink S., Arnold D., Wöhler A., et al., 2018; 309:148-159.

Home
Science
Investors
Pipeline

Home
Science
Investors
Pipeline

About

About Overview
Leadership

About Overview
Leadership

Patients

Clinical Trials
Spinal Cord Injury

Clinical Trials
Spinal Cord Injury

INVESTORS

Stock Information
Financial Information
Corporate Governance
News Releases
Events & Presentations
Analyst Coverage
In The Media

Stock Information
Financial Information
Corporate Governance
News Releases
Events & Presentations
Analyst Coverage
In The Media

CONTACT

112-970 Burrard Street Unit 1290
Vancouver, BC V6Z 2R4

Phone: (778) 731-1711

Email: info@nervgen.com

X Vector. Linkedin Vector.

© 2026 NervGen Pharma Corp. All rights reserved.

Privacy Policy
Cookie Policy
Terms and Conditions

Privacy Policy
Cookie Policy
Terms and Conditions

Biotech Web Design